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Brain structural correlates 
of functional capacity 
in first‑episode psychosis
Erkan Alkan1, Geoff Davies3,4, Kathy Greenwood2,3 & Simon L. Evans1*
Impaired functional capacity is a core feature of schizophrenia and presents even in first‑episode 
psychosis (FEP) patients. Impairments in daily functioning tend to persist despite antipsychotic 
therapy but their neural basis is less clear. Previous studies suggest that volume loss in frontal cortex 
might be an important contributor, but findings are inconsistent. We aimed to comprehensively 
investigate the brain structural correlates of functional capacity in FEP using MRI and a reliable 
objective measure of functioning [University of California, San Diego Performance‑Based Skills 
Assessment (UPSA)]. In a sample of FEP (n = 39) and a well‑matched control group (n = 21), we 
measured cortical thickness, gray matter volume, and white matter tract integrity (fractional 
anisotropy, FA) within brain regions implicated by previous work. The FEP group had thinner cortex 
in various frontal regions and fusiform, and reduced FA in inferior longitudinal fasciculus (ILF). In 
FEP, poorer functional capacity correlated with reduced superior frontal volume and lower FA in 
left ILF. Importantly, frontal brain volumes and integrity of the ILF were identified as the structural 
correlates of functional capacity in FEP, controlling for other relevant factors. These findings 
enhance mechanistic understanding of functional capacity deficits in schizophrenia by specifying the 
underlying neural correlates. In future, this could help inform intervention strategies.
Impaired functioning is a core feature of psychosis: individuals diagnosed with schizophrenia have poor long-
term outcomes in  social1 and  vocational2 functioning. Functional disability affects the overwhelming majority 
of schizophrenia patients and is present at all stages of the  illness2, 3. However, antipsychotic therapy has limited 
efficacy in improving functional  capacity4 with symptomatic remission much more frequently observed 
than functional  recovery2. Evidence suggests that functional impairment is linked to negative symptoms in 
particular: negative symptom severity explains substantial variance in functional capacity both at  baseline5,6 and 
over the longer-term7, in first episode psychosis (FEP).
However, the underlying neurobiology of functional impairment is not well understood, since relatively 
few studies have set out with a primary aim of investigating this in individuals with psychosis. A meta-analysis 
covering both FEP and chronic schizophrenia concluded that prefrontal cortex volume was the most consistent 
structural correlate of functional capacity although other regions (including limbic structures and ventricular 
enlargement) were also  implicated8. Considerable inconsistency in findings was noted, likely at least partially 
attributable to the heterogeneity of measures used and the fact that most studies explored the question only 
as a secondary or supplementary analysis. Some used the University of California, San Diego Performance-
Based Skills Assessment (UPSA), which assesses functional capacity for everyday life via a series of role-play 
simulations testing financial, transportation, household chores, communication, and planning  skills9. Other 
studies assessed functioning via clinician-rated measures such as the Global Assessment of Function (GAF) 
 scale10 or the Camberbell Assessment of Need (CAN) scale. Although well-used and less time-consuming than 
the UPSA, these measures tend to be less reliable and show lower validity in terms of measuring real-world 
 outcomes11. Others used subjective ratings of functional capacity, or more limited proxy measures such as 
socio-economic status (SES) (e.g. Takayanagi et al.12). Using comprehensive objective measures such as UPSA 
is crucial: it is the preferred methodology as it does not rely on patients’ self-insight13. However, the brain 
structural correlates of UPSA performance has to date only been investigated in schizophrenia, not  FEP14. The 
current study addresses this shortcoming in the literature.
In FEP, left prefrontal cortex volume has been shown to predict GAF-rated functional  capacity15 and 
social/occupational functioning 1 year  subsequent16. In ultra-high risk individuals, lower baseline volume in 
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middle and inferior frontal gyrus predicted a subsequent 9-year decline in GAF-rated  functioning17, while 
in schizophrenia, cortical thickness in middle/superior frontal has been linked to role functioning  ability18. 
Prefrontal cortex functional activation patterns correlate with both cognitive performance and global functioning 
in  FEP19, suggesting that prefrontal volume loss might impact functional capacity as a result of executive function 
impairment. Other studies have linked ventricular enlargement to poorer functional outcome in FEP measured 
using the CAN  scale20,21. In chronic schizophrenia, excessive ventricular enlargement has also been associated 
with poorer functional  outcome22. Volume in neighbouring regions also shows associations. Right insula volume 
has been linked to GAF-rated functional decline in  FEP23 and at-risk  individuals24. Uwatoko, et al.25 found 
that right insula volume correlated with occupational functioning which was assessed by the instrumental role 
category score of the Quality of Life Scale (QLS), in schizophrenia. They also reported that this relationship was 
mediated by negative symptoms. In a study which only focussed on subcortical structures, volume of the right 
thalamus correlated with UPSA scores in schizophrenia  patients14. Overall, evidence suggests that volume loss 
in prefrontal regions, ventricular enlargement, and reduced insula and thalamus volume might constitute the 
neural correlates of functional capacity in schizophrenia, although not all findings are consistent. Further, since 
social functioning is an important component of functional capacity, it might be expected that regions implicated 
in the processing of social stimuli would also contribute. Studies suggest that gray matter reduction in fusiform 
gyrus might underlie the poorer facial processing abilities often observed in  schizophrenia26. Accurate perception 
of social stimuli is critical for some aspects of functional capacity, but whether volume reduction in fusiform 
gyrus also contributes to functioning has not been explicitly tested. However, evidence does point to a role for 
white matter integrity within specific tracts, with fractional anisotropy (FA) being the most commonly used 
measure in the literature for measuring this. Karlsgodt, et al.27 found that FA in inferior longitudinal fasciculus 
(ILF) predicted subsequent deterioration in social and role functioning in 36 individuals at ultra-high risk of 
psychosis. In a sample of 30 patients with schizophrenia, Behdinan et al.28 found that FA of the ILF and arcuate 
fasciculus correlated with QLS scores, this relationship was mediated by negative symptoms. Thus, integrity 
of the ILF might be an important contributor to functional capacity: no studies have examined this in FEP but we 
address this here. Reduced FA in left ILF has been reported in FEP, however the significance of this is not  clear29.
Neuroimaging studies of individuals diagnosed with schizophrenia point to specific abnormalities in brain 
morphology associated with the disease and the aforementioned findings should be considered in this context. 
Ventricular enlargement is one of the most well-replicated of these and appears to be progressive in chronic 
 patients30. Most studies have shown that ventricular enlargement is also detectable in  FEP31,32 although this is not 
always replicated, e.g. Berger et al.33. In FEP, volumetric differences in other regions have been reported, although 
the literature is inconsistent. Overall, perhaps the most robust findings have been within fronto-temporal34,35 
and thalamo-cortical  networks36, and regarding the latter, it has been proposed that thalamic pathology might 
be pivotal to the disease due to the role of this structure in coordinating information flow within and between 
neural  networks37. In FEP, volumetric decreases in thalamus, insula, and anterior cingulate have been consistently 
 identified38. In addition, cortical thickness reductions have been reported, particularly across frontal  regions39–44 
although some studies have also identified thinning in parietal and temporal regions including fusiform  gyrus39,42. 
Regarding cortical thinning, the studies that have investigated this in FEP point to a fairly consistent pattern 
of thinning across frontal and parietal  cortices44 sometimes accompanied by thinning in temporal  regions42,45. 
However, Song et al.46 found only thinning in left insula and superior temporal gyrus.
In this study, we set out to investigate the brain structural correlates of functional capacity in FEP using 
UPSA, an optimal objective measure of functioning. Firstly, we used multiple regression to determine which 
demographic and symptom severity variables influenced UPSA scores: given previous findings, we expected 
negative symptoms to explain substantial variance. For the MRI analyses, we focused on volume, cortical 
thickness, and FA in specific regions of interest (ROIs) implicated by previous work. On these MRI measures, 
the FEP group was first contrasted with an age-, gender- and education- matched control group so as to 
contextualise the findings. Then we explored correlations between these measures and UPSA scores in the FEP 
group, controlling for the factors identified in the multiple regression analysis. This approach allowed us to focus 
specifically on the neurobiological correlates of functional capacity, independent of other explanatory variables.
Methods
Subjects. Ethical approval for the study was given by the London-Camden and Islington NHS Research 
and Ethics Committee (Ref: 11/LO/1877, project ID 72141). All research was performed in accordance with 
relevant guidelines and regulations. Written informed consent was obtained on the day of the study. 39 patients 
with FEP (9 females, age range 19–39, see Table 1) were recruited from Early Intervention in Psychosis services 
in Sussex Partnership NHS Foundation Trust (requiring duration of untreated psychosis < 2 years). Neuroleptic 
medication information was taken and converted to olanzapine and chlorpromazine equivalent  doses47. The 
short form of the Positive and Negative Syndrome  Scale48 was applied to assess patient’s symptoms.
A further 21 age, gender, and education -matched healthy controls were also recruited (5 females, age range 
18–38). For all participants, inclusion criteria were: age > 18 years, MRI safe, and no history of neurologic illness/
substance misuse. FEP participants were required to have a primary diagnosis of FEP, while controls had no 
history of psychiatric illness. Additional measures were included within the test session and results from these 
have been reported  elsewhere3, 49–52. In particular, please refer to Rae et al.52 for analyses of microstructural white 
matter abnormalities in this sample based on NODDI.
MRI acquisition. All imaging data was acquired with a Siemens Avanto 1.5 T scanner (Siemens Erlangen, 
Germany) using a 32-channel head coil and gradient strength 44 mT/m. To detect any artefacts, all images were 
visually inspected prior to analysis.
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T1 structural. A high-resolution T1-weighted structural image was acquired using an MPRAGE sequence with 
the following parameters: TR/TE = 2730 ms/3.57 ms; GRAPPA acceleration 2; an in-plane matrix of 256 × 256 
pixels over a FOV of 256 mm × 240 mm; flip angle 7°; slice thickness 1 mm yielding 192 sagittal plane slices; 
coronal and axial resolution 1 mm; acquisition time 5 min 58 s.
Gray matter volume and cortical thickness measurements. The gray matter volumes and cortical thickness 
measures were calculated by FreeSurfer 6.0.0 using the “recon-all” pipeline (https ://surfe r.nmr.mgh.harva 
rd.edu). Parcellation was based on the Destrieux  atlas53.
Neurite orientation dispersion and density imaging (NODDI). Three diffusion-weighted shells were acquired 
using b = 300, 800, and 2400 s/mm2 with 9, 30, and 60 unique non-colinear diffusion directions, respectively. In 
addition, 11 non-diffusion-weighted volumes (i.e. b ≈ 0) were acquired. A NODDI microstructural model was 
computed and fitted to the data using the NODDI toolbox for  MATLAB54 that provided measures of neurite 
density, orientation dispersion, and FA in native space. After normalisation, binarized masks (from the JHU 
white-matter tractography atlas included with  FSL55) were applied to calculate FA in the ILF.
Note. Further details regarding the pre-processing and the acquisition of T1 structural, gray matter volume, 
and cortical thickness measurements are presented in Supplementary Materials.
The University of California, San Diego Performance‑Based Skills Assessment 
(UPSA). Functional capacity was measured by the UCSD Performance-based Skills Assessment (UPSA)9. 
The UPSA is an instrument to assess the capacity to complete everyday tasks across 5 domains: finance, 
communication, comprehension and planning, transportation, and household chores. The UPSA has been 
assessed for reliability and validated in  schizophrenia56 and employed in FEP  before3,6,51,57. Of the 39 FEP 
participants, 34 completed the UPSA.
Statistical analysis. IBM SPSS Statistics 21.0 was used to conduct statistical analyses. On demographic 
variables, groups were compared using independent sample t tests (for age and years of education), and a χ2 test 
(for gender).
To identify significant predictors of UPSA in the FEP group, multiple linear regression analysis was performed 
(enter method): age, gender, years of education, PANNS negative, and chlorpromazine equivalent were entered 
as independent variables. Multicollinearity was observed to be low: the VIF values never approached or exceeded 
the generally-accepted critical value of 10, and in fact, were typically much lower (< 3).
For between-group comparisons of cortical thickness, an ROI approach was taken using regions that have 
been associated with functional capacity by previous studies. Specifically, as indicated by a meta-analysis8 
prefrontal cortex is most consistency implicated, with previous findings pointing to structural correlates across 
middle and lateral prefrontal  cortex15–17: as such we included Superior Frontal, Right VLPFC, Left VLPFC, 
Middle Frontal, Rostral Anterior Cingulate in our set of ROIs. Previous work has also implicated ventricular 
 enlargement20–22, right insula  volume23–25, and volume of the right  thalamus14 to poorer functional outcome; 
thus these regions were also included. We also included fusiform due to its role in the processing of social 
stimuli social functioning which is an important contributor to functional capacity; despite this, it has not been 
explored by previous work. For FA measures, we focused only on bilateral ILF as reduced FA in this tract has 
been consistently implicated in functional capacity by two prior  studies27,28. Group comparisons of the neural 
indices were analysed using analyses of covariance (ANCOVAs), with age and gender as covariates.
Thickness ROIs. Superior Frontal, Right VLPFC, Left VLPFC, Middle Frontal, Rostral Anterior Cingulate, 
Right Fusiform, Left Fusiform, Right Insula.
Volume ROIs. Superior Frontal, Right VLPFC, Left VLPFC, Middle Frontal, Rostral Anterior Cingulate, Right 
Fusiform, Left Fusiform, Right Insula, Right Thalamus, Right Lateral Ventricle, Left Lateral Ventricle.
Table 1.  Demographic characteristics and UPSA scores of the sample. FEP first-episode psychosis, M (SD) 
mean (standard deviation), PANSS Positive and Negative Syndrome Scale, N/A not applicable. a Independent 
sample t test, bPearson Chi-square.
Healthy control (N = 21) FEP (N = 39) p
Age, M (SD) 24.43 (5.62) 26.31 (5.57) 0.219a
Female (N, %) 5 (23.8%) 9 (23.1%) 0.949b
Education (years) (SD) 13.71 (1.76) 13.28 (1.68) 0.355a
Medication (olanzapine equivalent mg/day) (SD) N/A 13.15 (6.92) N/A
Medication (chlorpromazine equivalent mg/day) N/A 223.72 (274.56) N/A
PANSS (3 item) positive symptoms (mean) (SD) N/A 5.34 (2.40) N/A
PANSS (2 item) cognitive disorganisation (mean) (SD) N/A 3.31 (1.45) N/A
PANSS (3 item) negative symptoms (mean) (SD) N/A 5.74 (2.80) N/A
UPSA N/A 68.41 (19.18) N/A
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FA ROIs. Right ILF, Left ILF.
To investigate the relationships between functional capacity (UPSA) and brain structural measures (volume 
and thickness within the same ROIs), partial correlations were performed, with age, medication, and  PANSS- 
scores as control variables. To test the relationships between functional capacity (UPSA) and FA in ILF, partial 
correlations were performed. Previous published work using the NODDI data from these  participants52 showed 
that ILF FA was not related to medication or symptom severity, but there was an effect of age. Therefore age was 
included as a control variable in the FA partial correlation analyses.
Results
Demographic data of the study sample. No statistically significant differences were observed between 
FEP and healthy controls on any demographic variables (all p values > 0.05, see Table 1). In the FEP group, the 
mean UPSA score was 68.41 (SD = 19.18, N = 34), which is slightly lower than previous FEP studies in which 
their mean scores were 74.751 and 77.56.
Demographic and clinical predictors of UPSA. Age, gender, years of education, PANSS negative 
scores, and chlorpromazine equivalent were used as independent variables in a multiple linear regression model 
to predict the UPSA scores. Using the enter method, a statistically significant model emerged (F5,27 = 3.343, 
p = 0.018, adjusted R2 = 0.268). Negative symptom severity (p = 0.035) and medication (p = 0.024) were found to 
be significant predictors of UPSA scores (Table S1).
MRI—structural differences between FEP and controls. Between-group differences were assessed 
using ANCOVA with age and gender as covariates. Bonferroni-corrected thresholds for multiple comparisons 
were applied and the adjusted alpha values were 0.00625 (i.e., 0.05 divided by 8) for thickness, 0.0045 (i.e., 0.05 
divided by 11) for volume and 0.025 for FA (i.e., 0.05 divided by 2) within the preselected ROIs.
Cortical thickness. After correction for multiple comparisons, thinner cortices were observed in FEP within 
superior frontal, middle frontal, right VLPFC, and right fusiform. The results also suggested that FEP had 
thinner cortices in left VLPFC, left fusiform, and right insula, although these did not survive correction for 
multiple comparisons. There were no statistically significant differences in rostral anterior cingulate (Table 2).
Gray matter volume and ventricle differences. Results suggested that FEP had lower volume in right hemisphere 
thalamus, and larger lateral ventricles (bilaterally). However, these differences were not significant after multiple 
comparisons. There were no statistically significant differences in the other ROIs (Table 2).
FA differences. FEP had reduced FA in the right and left ILF compared to healthy controls; these differences 
survived correction for multiple comparisons (Bonferroni corrected p < 0.025) (Table 2).
Correlations between UPSA scores and MRI measures. Partial correlation analyses (controlling for 
age, medication, and PANNS negative scores) were performed to investigate the relationships between UPSA 
and MRI measures. As above, a Bonferroni correction for multiple comparisons was employed and the adjusted 
alpha values were 0.00625 (i.e., 0.05 divided by 8) for thickness, 0.0045 (i.e., 0.05 divided by 11) for volume and 
0.025 for FA (i.e., 0.05 divided by 2).
Grey matter volume. UPSA scores in FEP positively correlated with superior frontal volume (see Fig.  1a; 
Table  3) after correction for multiple comparisons. Associations were also seen in bilateral fusiform, rostral 
anterior cingulate, right VLPFC, and right insula, but these did not survive correction for multiple comparisons. 
No associations were seen in the middle frontal, left VLPFC, thalamus, and lateral ventricle (Table 3).
Cortical thickness correlates. UPSA scores in FEP group did not significantly correlate with thickness in any of 
the ROIs (all p values > 0.05) (Table S2).
FA correlates. UPSA scores in FEP group positively correlated with FA in left ILF, this relationship survived 
correction for multiple comparisons (see Fig. 1b; Table 3).
Discussion
Our primary aim was to comprehensively determine the brain structural correlates of functional capacity in 
FEP. As context, we also analysed brain structural differences between FEP and a healthy control group. In line 
with previous findings, PANNS negative scores and medication use explained significant variance in UPSA 
scores. Previous studies suggest negative symptoms are the strongest symptomatic contributor to poor functional 
capacity in  FEP5,6 and  schizophrenia58. Likewise, in the present study negative symptoms emerged as a significant 
predictor of UPSA scores and underscores the importance of addressing negative symptoms as a treatment goal 
so as to promote better functioning in FEP.
Relative to the control group, FEP had thinner cortex in superior frontal, VLPFC, middle frontal, and 
fusiform. This accords with previous studies that point to consistent cortical thinning, particularly in frontal 
 regions41,42,45,59. These differences were not apparent when volume rather than cortical thickness was tested, 
however. Some previous work suggests that cortical thickness might be the more sensitive  measure60. Cortical 
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thickness reflects the density and size of neuronal cells and neuropil (axons + dendrites + glia)60,61 and postmortem 
studies in schizophrenia point to reductions in these parameters, while the actual number of neurons appears 
to be  unaffected62,63. Thus reduced cortical thickness and volumetric indices in schizophrenia are assumed to 
reflect these  alterations64.
The volumetric analysis did point to ventricular enlargement and reduced volume in right thalamus in the 
FEP group, although these did not survive correction for multiple comparisons. Ventricular enlargement in FEP 
is a common  finding31,32,65 as is reduced volume in right  thalamus36,38. We also explored FA in the ILF, based on 
Table 2.  Cortical thickness, volumes (expressed as percentage of total intracranial volume) and FA in 
ILF, group comparisons (ANCOVA, age and gender covariates). HC healthy controls, FEP first episode 
of psychosis, VLPFC ventrolateral prefrontal cortex, FA fractional anisotropy, ILF inferior longitudinal 
fasciculus. ***Significant after Bonferroni’s correction for multiple comparisons at p < 0.025, for FA differences, 
**Significant after Bonferroni’s correction for multiple comparisons at p < 0.00625, for cortical thickness 




Superior frontal 2.76 2.63 10.813** 0.002
Right VLPFC 2.63 2.51 10.604** 0.002
Left VLPFC 2.62 2.51 8.056* 0.006
Middle frontal 2.50 2.39 10.077** 0.002
Rostral anterior cingulate 2.73 2.69 0.212 0.647
Right fusiform 2.72 2.62 9.818** 0.003
Left fusiform 2.70 2.63 5.134* 0.027





Superior frontal 1.37 1.32 1.179 0.282
Right VLPFC 0.22 0.22 0.097 0.756
Left VLPFC 0.22 0.21 0.237 0.628
Middle frontal 0.68 0.67 0.057 0.811
Rostral anterior cingulate 0.15 0.15 0.005 0.943
Right fusiform 0.62 0.61 0.448 0.506
Left fusiform 0.64 0.63 0.373 0.544
Right thalamus 0.48 0.46 5.291* 0.025
Right lateral ventricle 0.26 0.41 5.143* 0.027
Left lateral ventricle 0.30 0.43 5.093* 0.028
Right insula 0.43 0.41 1.345 0.251
FA Mean FA F p
Right ILF 0.4689 0.4446 6.865*** 0.011
Left ILF 0.4478 0.4287 6.497*** 0.014
Figure 1.  Scatterplots of functional capacity (UPSA) against ICV-adjusted superior frontal volume and FA 
in left ILF. (a) Larger superior frontal volume correlated with higher functional capacity. (b) FA in left ILF 
correlated positively with functional capacity.
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evidence linking this parameter to functional capacity in patients with  schizophrenia27,28. Relative to controls, 
we found FEP to have reduced FA in both right and left ILF, which is in line with the previous findings. Hatton, 
et al.29 and Ashtari, et al.66 found reduced FA in the left ILF in young adult FEP patients, suggesting that reduced 
FA in this tract might be an important neural marker during the early stages of the disease.
The main focus of the current study was to investigate the structural correlates of functional capacity. A 
reliable objective measure (UPSA) was used and analyses investigated correlations between UPSA scores and 
brain structural indices within a set of brain structures implicated in previous studies. PANNS negative scores and 
medication use were controlled for in the analyses. The current paper represents a more thorough investigation 
compared to previous studies, many of which only investigated the links between structure and functional 
capacity as a secondary aim, or used a non-optimal measure of  functioning8,11. A previous study employing UPSA 
identified a positive relationship between right hemisphere thalamus volume and UPSA scores in patients with 
 schizophrenia14 but the current study is the first to comprehensively test brain structural correlates of functional 
capacity using UPSA in an FEP sample. After correction for multiple comparisons, superior frontal volume was 
seen to positively correlate with UPSA score (p = 0.003). Positive correlations were also observed with other 
frontal regions (right superior frontal, right VLPFC, rostral anterior cingulate), although these did not survive 
correction for multiple comparisons. Positive relationships between functioning and volume in frontal regions 
have been found previously in  FEP15,16. Frontal volumetric reduction could lead to cognitive dysfunction and 
associated difficulties with daily functioning. Links between cognitive deficits and poor real-world functioning 
are well established in  schizophrenia67,68. For example, in schizophrenia, links between language ability and UPSA 
have been  identified69, correlations between global cognitive performance and UPSA have also been  shown70 
although not necessarily across all UPSA  domains71. In terms of underlying mechanisms, greater brain surface 
contraction in the 2 years after first episode of psychosis has been shown in dorsal frontal regions, compared to 
 controls72, possibly reflecting an increased rate of synaptic pruning. Here, the fact that UPSA correlations were 
seen with volume rather than thickness measures is noteworthy. Brain volume is a function of both cortical 
surface area and thickness. Surface area and thickness appear to be both phenotypically and genetically distinct. 
Cortical thickness has been shown to be largely uncorrelated with surface area and volume estimates and is 
influenced by different genetic  factors73,74. On the other hand, grey matter volume generally correlates with 
cortical surface  area74. Investigations in patients with schizophrenia have found regions where grey matter 
volume reduction is present in the absence of cortical  thinning75–77 and this might be attributable to surface area 
changes. Indeed, Kong et al.78 identified regions (including superior frontal gyrus) where volume and thickness 
are discrepant, and subsequent ROI analyses demonstrated that changes in surface area and curvature could 
account for the discrepancy. Here, UPSA scores correlated with superior frontal volume but not thickness, 
suggesting that surface parameters in frontal regions could be a factor. Previous studies have found reduced 
cortical area in patients with schizophrenia (including in parietal, temporal, and medial frontal areas). Rimol 
et al.60 found that while cortical thinning accounted for most of the volumetric differences between patients and 
controls, it was reduced surface area that explained volumetric differences between schizophrenia and bipolar 
patients. Analyses of surface area parameters were beyond the scope of the current study, but future work could 
consider these to investigate the contribution of frontal surface area parameters to functional capacity.
We took a conservative approach to correcting for multiple comparisons (Bonferroni). Although this 
stringency increases the confidence in our findings, it raises the risk of committing Type 2 errors. Therefore, 
it worth noting the correlations between UPSA and fusiform (left and right) as well as right insula volumes 
Table 3.  Brain structural (volumetric) correlates of UPSA (partial correlations, controlling for  PANNS-, age, 
and medication). FA (in ILF) correlates of UPSA (partial correlations, controlling for age). PANNS− PANNS 
negative, VLPFC ventrolateral prefrontal cortex, FA fractional anisotropy, ILF inferior longitudinal fasciculus. 
**Significant after Bonferroni’s correction for multiple comparisons at p < 0.0045 for volumes and p < 0.025 for 
FA; *Significant at an uncorrected threshold, p < 0.05.
r p
Volumes
Superior frontal 0.524** 0.003
Middle frontal 0.307 0.099
Rostral anterior cingulate 0.445* 0.014
Right VLPFC 0.364* 0.048
Left VLPFC 0.146 0.440
Right fusiform 0.400* 0.028
Left fusiform 0.401* 0.028
Right thalamus − 0.210 0.266
Right lateral ventricle − 0.082 0.666
Left lateral ventricle − 0.175 0.354
Right insula 0.418* 0.021
FA
Right ILF 0.119 0.524
Left ILF 0.461** 0.009
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which did not survive multiple comparisons correction. Right insula volume has been linked to functional 
capacity in at-risk  individuals24;  FEP23 and  schizophrenia25. This could reflect the putative role of this structure 
in coordinating information flow within and between neural  networks37. The possible links between UPSA and 
fusiform volumes are also interesting. Previous studies on functional capacity have neglected to include fusiform 
within their choice of ROIs, instead often focusing on frontal structures. The accurate appraisal of social stimuli 
is important for optimal functioning, therefore it is perhaps to be expected that reduced fusiform volumes, which 
have been linked to poorer facial processing abilities in  schizophrenia26, might contribute to functional capacity 
scores. These correlations merit further exploration in an expanded sample. No links were found here between 
ventricular enlargement and functional capacity. This does not accord with previous work in  FEP20,21, although 
these studies used the CAN scale which focuses on the health and social needs of the patient, whereas UPSA 
assesses the capacity to complete everyday tasks across several distinct domains.
Finally, we also investigated white matter integrity within the ILF. Lower FA was evident in the FEP group in 
both right and left ILF. Previous work has identified reduced FA in the left ILF in  FEP29,66. This was also found by 
a study in adolescents with  schizophrenia66, with reduced FA in this tract associated with visual hallucinations. 
Reductions in right ILF FA have been identified in schizophrenia samples and linked to the severity of positive 
 symptoms79 and thinking  disorder80. Associations between FA in ILF and functional capacity have been identified 
in ultra-high  risk27 and  schizophrenia28 samples but not before studied in FEP. The ILF connects brain regions 
that are important for social cognition abilities (including fusiform gyrus and amygdala). Indeed, a study in 
healthy controls found that FA in ILF correlated with facial emotion detection  accuracy81; studies in other 
patient populations confirm this  relationship82. Here, we found FA in left ILF to correlate with UPSA scores in 
FEP, demonstrating that microstructural abnormalities in this tract have direct consequences for functioning 
in this patient group. This could be driven by its impact on social cognition ability; future work should explore 
this possibility. Concerns have been raised regarding the reliability of FA as a marker of white matter integrity, 
since it is unduly impacted by crossing  fibers83. Newer, more sensitive measures have been proposed and should 
be considered in future  work84.
This study benefits from the use of a matched control group and (unlike many previous studies) the inclusion 
of a rigorous, objective measure of functioning (UPSA). Although time-consuming, this measure has been 
suggested to be more reliable and to have higher validity, thus enhancing confidence in our  findings11. This is 
the first study to use UPSA in exploring the brain structural correlates of functioning in FEP; also, compared to 
previous work, a broader range of structural MRI metrics were employed. Study weaknesses include a relatively 
modest sample size and the lack of a cognitive task battery, which would have allowed the mediating effect of 
cognitive ability to have been assessed.
In conclusion, this study identified brain structural differences in FEP, including thinner cortex in frontal 
regions and fusiform gyrus, and reduced FA in ILF. This concurs with previous findings. The consequences of 
these for functional capacity (UPSA score) were then comprehensively explored and volumetric (rather than 
cortical thickness) measures in frontal regions showed the strongest correlations. This suggests that, in FEP, loss of 
surface area in frontal cortex might have important consequences for functional capacity. A possible relationship 
with fusiform volume was also observed. Further, FA in left ILF showed a strong correlation with UPSA scores, 
suggesting that abnormalities in this tract, likely impairing connectivity between regions important for social 
cognition, are also important contributors to poor functional capacity in FEP. Identifying the brain structural 
correlates of poor functional capacity in FEP points to the neurobiological mechanisms that underlie functional 
impairment, this line of enquiry is especially important given that functional capacity shows only limited 
response to antipsychotic treatment.
Data availability
The datasets generated during the current study are available from the corresponding author on reasonable 
request.
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